What’s New in Imaging: 3D Planning for Structural Heart Interventions
Dee Dee Wang, MD, FACC, FASE, FSCCT, Director of Structural Heart Imaging and 3D Printing, Henry Ford Health System, Detroit, USA
As part of the CSI webinar series, Dr. Wang from the Henry Ford Health System presents during the “What’s New in Imaging” webinar. Within this webinar she highlights challenges and limitations she sees in imaging for transcatheter interventions, the power of 3D planning, and tricuspid replacement as a case example.
In this webinar recording, you will:
Explore the latest technology in transcatheter planning and imaging
Learn how planning can impact procedural success
Comprehend the difference in perception of anatomy with 2D imaging vs 3D planning
Materialise medical device software may not be available in all markets because product availability is subject to the regulatory and/ or medical practices in individual markets. In countries where no regulatory registration is obtained of Mimics and/or 3-matic Medical, a research version is available. Please contact your Materialise representative if you have questions about the availability of Materialise medical device software in your area.
Dee Dee Wang,
MD, FACC, FASE, FSCCT
Henry Ford Health System, USA
Dr. Wang is a Level 3 Cocats trained in echocardiography (with 3D TEE), nuclear, and cardiac CTA; and a Level 2 Cocats trained in cardiac MRI and cardiac PET. She specializes in interventional imaging in structural heart interventions including transcatheter mitral valve replacement therapies, tricuspid interventions, mitral e-clip, complex TAVRs/adult-congenital cases, LAA interventions, and ASD/PFO closures. Dr. Wang’s research interests are focused on advancing patient safety and procedural outcomes utilizing 3D+4D imaging and 3D printing for high-risk structural heart interventions.